
|Poll|February 8, 2022
POLL: Which AD comorbidities were most interesting?
Author(s)Dermatology Times Staff
Click to answer this week's poll on the newly released AAD guidelines on AD comorbidites.
Advertisement
The AAD has recently released guidlines on AD and its association with other conditions. Which section was more intriguing to you?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5

















